TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2‐mediated glycolysis

Ample evidence reveals that glycolysis is crucial to tumor progression; however, the underlying mechanism of its drug resistance is still worth being further explored. TRAF6, an E3 ubiquitin ligase, is well recognized to overexpress in various types of cancer, which predicts a poor prognosis. In our...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Han, Li, Longzhi, Dong, Bing, Lu, Ji, Zhou, Kun, Yin, Xiaoxing, Sun, Huizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587986/
https://www.ncbi.nlm.nih.gov/pubmed/37746908
http://dx.doi.org/10.1002/cam4.6552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587986/
https://www.ncbi.nlm.nih.gov/pubmed/37746908
http://dx.doi.org/10.1002/cam4.6552

Ejemplares similares